Research Site

Fairway, Kansas 66205

3 studies enrolling now · 10 studies all time

What they study most

Advanced Solid Tumor, Breast Cancer, Breast Cancer, Early Breast Cancer, COVID-19, DGF, DLBCL, Delayed Graft Function, Dermatomyositis, Gastroesophageal Adenocarcinoma, Kidney Transplant, Polymyositis, Dermatomyositis, Richter Syndrome

Studies at this site

• A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma — Recruiting now
• An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) — Recruiting now
• Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation — Recruiting now
• A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis) — Recruiting now
• Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer — Running, not enrolling
• Ravulizumab Versus Placebo in Adult Participants With Dermatomyositis — Stopped early
• Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults — Completed
• A Phase 1 Study of the CD73 Inhibitor(HLX23) Alone in Participants With Solid Tumor — Withdrawn before enrolling
• A Study of Acalabrutinib and Vistusertib in Subjects With Relapsed/Refractory B-cell Malignancies — Stopped early
• A Phase I Study to Evaluate the Safety, Tolerability and Efficacy of MEDI4736 (Durvalumab) With Tremelimumab in Head and Neck Cancer — Completed